David M. Ota

7.9k total citations · 1 hit paper
112 papers, 5.1k citations indexed

About

David M. Ota is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, David M. Ota has authored 112 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 39 papers in Surgery and 31 papers in Molecular Biology. Recurrent topics in David M. Ota's work include Colorectal Cancer Surgical Treatments (23 papers), Colorectal and Anal Carcinomas (18 papers) and Glycosylation and Glycoproteins Research (13 papers). David M. Ota is often cited by papers focused on Colorectal Cancer Surgical Treatments (23 papers), Colorectal and Anal Carcinomas (18 papers) and Glycosylation and Glycoproteins Research (13 papers). David M. Ota collaborates with scholars based in United States, Japan and Switzerland. David M. Ota's co-authors include Karen R. Cleary, Tatsuro Irimura, Paul F. Mansfield, Boris W. Kuvshinoff, Jaffer A. Ajani, Tyvin A. Rich, Bruno D. Fornage, Mary Ann Gregurich, John M. Skibber and Bernard Levin and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

David M. Ota

111 papers receiving 4.9k citations

Hit Papers

Complications and Failures of Subclavian-Vein Catheteriza... 1994 2026 2004 2015 1994 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Complications and Failures of Subclavian-Vein Catheterization
    1994 504 citations Paul F. Mansfield, Bruno D. Fornage et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Ota United States 37 1.8k 1.8k 1.4k 1.4k 631 112 5.1k
Roderich E. Schwarz United States 42 2.0k 1.1× 2.2k 1.2× 1.2k 0.8× 2.4k 1.8× 434 0.7× 184 5.7k
Marcella M. Johnson United States 41 756 0.4× 2.9k 1.6× 1.5k 1.1× 895 0.7× 557 0.9× 74 5.4k
Alan S. Livingstone United States 46 2.8k 1.5× 1.9k 1.1× 728 0.5× 2.1k 1.6× 311 0.5× 227 6.6k
Francesco Tonelli Italy 33 1.5k 0.8× 1.5k 0.8× 510 0.4× 441 0.3× 690 1.1× 141 5.3k
Louis M. Fink United States 50 1.3k 0.7× 1.4k 0.8× 2.6k 1.9× 954 0.7× 284 0.5× 141 7.1k
Martin J. Heslin United States 41 2.0k 1.1× 3.1k 1.7× 1.0k 0.8× 2.1k 1.6× 215 0.3× 142 6.2k
İbrahim C. Haznedaroğlu Türkiye 37 1.4k 0.7× 642 0.4× 733 0.5× 589 0.4× 468 0.7× 355 5.6k
Beng H. Chong Australia 51 3.9k 2.1× 467 0.3× 1.3k 0.9× 927 0.7× 1.1k 1.8× 211 11.1k
Suguru Hasegawa Japan 34 1.8k 1.0× 2.3k 1.3× 850 0.6× 962 0.7× 401 0.6× 194 4.2k
Richard A. Prinz United States 46 4.1k 2.3× 2.5k 1.4× 1.2k 0.8× 1.2k 0.9× 299 0.5× 245 7.7k

Countries citing papers authored by David M. Ota

Since Specialization
Citations

This map shows the geographic impact of David M. Ota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Ota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Ota more than expected).

Fields of papers citing papers by David M. Ota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Ota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Ota. The network helps show where David M. Ota may publish in the future.

Co-authorship network of co-authors of David M. Ota

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Ota. A scholar is included among the top collaborators of David M. Ota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Ota. David M. Ota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McDonald, Sandra, Elaine R. Mardis, David M. Ota, et al.. (2012). Comprehensive Genomic Studies. American Journal of Clinical Pathology. 138(1). 31–41. 8 indexed citations
2.
McCarter, Martin D., Cristina R. Antonescu, Karla V. Ballman, et al.. (2012). Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence. Journal of the American College of Surgeons. 215(1). 53–59. 126 indexed citations
3.
Jacobs, Lisa K., et al.. (2007). The Audit Process and How to Ensure a Successful Audit. Cancer treatment and research. 132. 179–197. 1 indexed citations
4.
You, Yuyi, et al.. (2006). Improved Surgeon Performance in Clinical Trials: An Analysis of Quality Assurance Audits from the American College of Surgeons Oncology Group. Journal of the American College of Surgeons. 203(3). 269–276. 7 indexed citations
5.
You, Y. Nancy, Kelly K. Hunt, Mitchell C. Posner, et al.. (2006). Operative trials: the opportunity beckons—an update on the American College of Surgeons Oncology Group. Surgery. 139(4). 455–459. 6 indexed citations
6.
Newman, Lisa A., Cheryl T. Lee, Andrew K. Stewart, et al.. (2005). Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients. Cancer. 106(1). 188–195. 32 indexed citations
7.
Lin, Kevin M., Tarak H. Patel, Adrian S. Ray, et al.. (2004). Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. Journal of the American College of Surgeons. 199(4). 561–566. 47 indexed citations
8.
Ota, David M.. (2003). What’s New in General Surgery: Surgical Oncology. Journal of the American College of Surgeons. 196(6). 926–932. 2 indexed citations
9.
Kuvshinoff, Boris W., et al.. (1998). Surgical management of aberrant sentinel lymph node drainage in cutaneous melanoma. Surgery. 124(4). 757–762. 36 indexed citations
10.
Ota, David M.. (1997). Colon cancer. Cancer treatment and research. 90. 347–356. 8 indexed citations
11.
Ota, David M., et al.. (1995). Virtual reality in surgical education. Computers in Biology and Medicine. 25(2). 127–137. 124 indexed citations
12.
Kim, Yeul Hong, Jaffer A. Ajani, David M. Ota, Patrick M. Lynch, & Jack A. Roth. (1995). Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach. Cancer. 75(2). 451–456. 33 indexed citations
13.
Rich, Tyvin A., John M. Skibber, Jaffer A. Ajani, et al.. (1995). Preoperative infusional chemoradiation therapy for Stage T3 rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 32(4). 1025–1029. 231 indexed citations
14.
Mansfield, Paul F., et al.. (1994). Complications and Failures of Subclavian-Vein Catheterization. New England Journal of Medicine. 331(26). 1735–1738. 504 indexed citations breakdown →
15.
Nelson, Heidi, et al.. (1994). Laparoscopic-Assisted Segmental Colectomy: Surgical Techniques. Mayo Clinic Proceedings. 69(9). 825–833. 19 indexed citations
16.
Lippman, S. M., David Parkinson, Loretta M. Itri, et al.. (1992). 13-cis-Retinoic Acid and Interferon   -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin. JNCI Journal of the National Cancer Institute. 84(4). 235–241. 305 indexed citations
17.
Ellis, Lee M., Douglas B. Evans, Donald R. Martin, & David M. Ota. (1992). Laparoscopic feeding jejunostomy tube in oncology patients. Surgical Oncology. 1(3). 245–249. 17 indexed citations
18.
Ota, David M., et al.. (1991). Amelioration of thrombocytopenia with concomitant ornithine in sarcomabearing rats receiving high dose difluoromethylornithine. Investigational New Drugs. 9(4). 321–326. 1 indexed citations
19.
Ajani, Jaffer A., David M. Ota, J. Milburn Jessup, et al.. (1991). Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy. Cancer. 68(7). 1501–1506. 125 indexed citations
20.
Ota, David M., et al.. (1983). Effect of serum source on protein-free diet lymphocyte blastogenesis. Journal of Surgical Research. 35(3). 243–248. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roderich E. Schwarz Breakdown of academic impact, for papers by Marcella M. Johnson Breakdown of academic impact, for papers by Alan S. Livingstone Breakdown of academic impact, for papers by Francesco Tonelli Breakdown of academic impact, for papers by Louis M. Fink Breakdown of academic impact, for papers by Martin J. Heslin Breakdown of academic impact, for papers by İbrahim C. Haznedaroğlu Breakdown of academic impact, for papers by Beng H. Chong Breakdown of academic impact, for papers by Suguru Hasegawa Breakdown of academic impact, for papers by Richard A. Prinz
Rankless by CCL
2026